Literature DB >> 18345306

Is there a role for estrogen and progesterone receptors in gall bladder cancer?

P J Shukla1, S G Barreto, P Gupta, R Neve, M Ramadwar, K Deodhar, S Mehta, S V Shrikhande, K M Mohandas.   

Abstract

BACKGROUND/AIMS: The concept of metaplastic and non-metaplastic types of gall bladder cancer and the likelihood of hormone receptor expression in the nuclei of tumour cells raised the possibility of a potential role for anti-estrogen therapy in gall bladder cancer. This study was carried out to determine the hormone receptors (ER/PR) expression level in gall bladder cancer using specific immunohistochemical assays and correlate it with patient and tumour histopathological characteristics. PATIENTS AND METHODS: Histopathological tumour specimens of 62 patients who underwent a radical cholecystectomy were analysed. Pronase pretreatment and primary monoclonal antibodies were used to perform immunohistochemical analysis for ER and PR.
RESULTS: The histology was adenocarcinoma--predominantly, moderately to poorly differentiated (91%). Gallstones were present in 90% of the individuals. Of the 62 specimens analysed, 62 (100%) and 61 (98%) were negative for ER and PR, respectively.
CONCLUSION: The high incidence of gallstone-related gall bladder cancer in India is associated with metaplasia and a tendency to poorer differentiation in the tumour histology. These tumours are consequently less likely to express hormone receptors. Thus, there does not seem to be a role for anti-hormone therapy in patients with histogenesis similar to that seen in India.

Entities:  

Keywords:  estrogen receptor; gall bladder cancer; immunohistochemistry; progesterone receptor

Year:  2007        PMID: 18345306      PMCID: PMC2215398          DOI: 10.1080/13651820701481489

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  19 in total

1.  Immunohistochemical analysis of estrogen receptors in human gallbladder.

Authors:  M Yamamoto; S Nakajo; E Tahara
Journal:  Acta Pathol Jpn       Date:  1990-01

2.  Overexpression of p53 protein in gallbladder carcinoma in North India.

Authors:  S Misra; A Chaturvedi; M M Goel; R Mehrotra; I D Sharma; A N Srivastava; N C Misra
Journal:  Eur J Surg Oncol       Date:  2000-03       Impact factor: 4.424

Review 3.  Papillary carcinoma of the gallbladder and anomalous pancreatico-biliary junction. Report of three cases and review of the literature.

Authors:  Gennaro Nuzzo; Gennaro Clemente; Federica Cadeddu; Francesco Ardito; Riccardo Ricci; Fabio M Vecchio
Journal:  Hepatogastroenterology       Date:  2005 Jul-Aug

4.  Gene mutations of K-ras in gallbladder mucosae and gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct.

Authors:  K Hanada; A Tsuchida; T Iwao; N Eguchi; T Sasaki; K Morinaka; K Matsubara; Y Kawasaki; S Yamamoto; G Kajiyama
Journal:  Am J Gastroenterol       Date:  1999-06       Impact factor: 10.864

5.  Bowel movement frequency, medical history and the risk of gallbladder cancer death: a cohort study in Japan.

Authors:  Kiyoko Yagyu; Yingsong Lin; Yuki Obata; Shogo Kikuchi; Teruo Ishibashi; Michiko Kurosawa; Yutaka Inaba; Akiko Tamakoshi
Journal:  Cancer Sci       Date:  2004-08       Impact factor: 6.716

6.  Estrogen receptors in gallbladder cancer: detection by an improved immunohistochemical assay.

Authors:  C Y Ko; P Schmit; L Cheng; J E Thompson
Journal:  Am Surg       Date:  1995-10       Impact factor: 0.688

7.  Histogenesis of well-differentiated adenocarcinoma of the gallbladder.

Authors:  M Yamamoto; S Nakajo; E Tahara
Journal:  Pathol Res Pract       Date:  1989-03       Impact factor: 3.250

8.  Immuno-histochemical analysis of estrogen receptors on the malignant gallbladder tissue.

Authors:  I A Malik; Z Abbas; Z Shamsi; I Daudi; H A Shah; I Moid; Z K Khan; H Shaikh
Journal:  J Pak Med Assoc       Date:  1998-05       Impact factor: 0.781

9.  Proliferative potential and K-ras mutation in epithelial hyperplasia of the gallbladder in patients with anomalous pancreaticobiliary ductal union.

Authors:  S Tanno; T Obara; T Fujii; Y Mizukami; R Shudo; N Nishino; H Ura; A J Klein-Szanto; Y Kohgo
Journal:  Cancer       Date:  1998-07-15       Impact factor: 6.860

10.  p53 protein overexpression in gallbladder carcinoma and its precursor lesions: an immunohistochemical study.

Authors:  I I Wistuba; A F Gazdar; I Roa; J Albores-Saavedra
Journal:  Hum Pathol       Date:  1996-04       Impact factor: 3.466

View more
  10 in total

1.  Surgery for gallbladder cancer: The need to generate greater evidence.

Authors:  Shailesh V Shrikhande; Savio G Barreto
Journal:  World J Gastrointest Surg       Date:  2009-11-30

2.  Female sex hormone receptors in gallbladder cancer.

Authors:  Ramanathan Saranga Bharathi; Rajinder Singh; Rajesh Gupta; Ganga Ram Verma; Naveen Kalra; K Kiran; Kusum Joshi
Journal:  J Gastrointest Cancer       Date:  2015-06

3.  Expression and clinicopathological significance of estrogen and progesterone receptors in gallbladder cancer.

Authors:  Parul Gupta; Asha Agarwal; Vishal Gupta; Prem K Singh; Chayanika Pantola; Sonal Amit
Journal:  Gastrointest Cancer Res       Date:  2012-03

Review 4.  Pathology of gallbladder carcinoma: current understanding and new perspectives.

Authors:  Munita Meenu Bal; Mukta Ramadwar; Kedar Deodhar; Shailesh Shrikhande
Journal:  Pathol Oncol Res       Date:  2015-01-25       Impact factor: 3.201

5.  Hormones and gallbladder cancer in women.

Authors:  Savio G Barreto; Hirofumi Haga; Parul J Shukla
Journal:  Indian J Gastroenterol       Date:  2009-11-24

Review 6.  Systematic review: should routine resection of the extra-hepatic bile duct be performed in gallbladder cancer?

Authors:  Parul J Shukla; Savio G Barreto
Journal:  Saudi J Gastroenterol       Date:  2010 Jul-Sep       Impact factor: 2.485

7.  Expression of Female Sex Hormone Receptors, Connective Tissue Growth Factor and HER2 in Gallbladder Cancer.

Authors:  Beata Hryciuk; Rafał Pęksa; Michał Bieńkowski; Bartosz Szymanowski; Barbara Radecka; Kamil Winnik; Jolanta Żok; Natalia Cichowska; Mariola Iliszko; Renata Duchnowska
Journal:  Sci Rep       Date:  2020-02-05       Impact factor: 4.379

8.  Diagnostic and Prognostic Impact of Progesterone Receptor Immunohistochemistry: A Study Evaluating More Than 16,000 Tumors.

Authors:  Florian Viehweger; Lisa-Marie Tinger; David Dum; Natalia Gorbokon; Anne Menz; Ria Uhlig; Franziska Büscheck; Andreas M Luebke; Claudia Hube-Magg; Andrea Hinsch; Doris Höflmayer; Christoph Fraune; Patrick Lebok; Sören Weidemann; Maximilian Lennartz; Frank Jacobsen; Till S Clauditz; Rainer Krech; Till Krech; Andreas H Marx; Ronald Simon; Eike Burandt; Stefan Steurer; Guido Sauter; Sarah Minner; Christian Bernreuther
Journal:  Anal Cell Pathol (Amst)       Date:  2022-08-08       Impact factor: 4.133

Review 9.  A genetic model for gallbladder carcinogenesis and its dissemination.

Authors:  S G Barreto; A Dutt; A Chaudhary
Journal:  Ann Oncol       Date:  2014-04-04       Impact factor: 32.976

10.  Expression of Human epidermal growth factor receptor 2, Survivin, Enhancer of zeste homolog -2, Cyclooxygenase-2, p53 and p16 molecular markers in Gall bladder carcinoma.

Authors:  Amit Gupta; Sweety Gupta; Rishit Mani; Prashant Durgapal; Bela Goyal; Deepak Rajput; Shalinee Rao; Puneet Dhar; Manoj Gupta; Sanjeev Kishore; Ravi Kant
Journal:  J Carcinog       Date:  2021-06-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.